Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Shares, without par value
-
Shares outstanding
-
193,394,759
-
Total 13F shares
-
35,268
-
Share change
-
-1,094,791
-
Total reported value
-
$93,574
-
Price per share
-
$2.18
-
Number of holders
-
11
-
Value change
-
-$3,027,847
-
Number of buys
-
2
-
Number of sells
-
21
Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q2 2022
As of 30 Jun 2022,
Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,268 shares.
The largest 10 holders included
Wealth Management Associates, Inc., Allspring Global Investments Holdings, LLC, Federation des caisses Desjardins du Quebec, GPS Wealth Strategies Group, LLC, FRANKLIN RESOURCES INC, TCI Wealth Advisors, Inc., HARBOR INVESTMENT ADVISORY, LLC, WELLS FARGO & COMPANY/MN, Point72 Hong Kong Ltd, and HANTZ FINANCIAL SERVICES, INC..
This page lists
11
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.